WECONNECT
Live / Applied — Second extension granted (statement of use) (as of 20 Feb 2026)
What this means for you
Not registered yet, but its 29 Feb 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98427814
- Mark type
- Stylized text
- Filed
- 29 Feb 2024
- Published for opposition
- 25 Feb 2025
- Attorney of record
- Karl M. Zielaznicki, Esq.
Goods and services
- Class 035 — Advertising and business services: Providing advertising information in the field of patient recruitment for clinical trials via a website
- Class 041 — Education and entertainment services: Publication of brochures, pamphlets, newsletters, manuals, books, flyers, and leaflets featuring the results of clinical trials
- Class 042 — Scientific and technological services: Providing information in the field of clinical research via a website; providing medical and scientific information in the field of clinical trials; providing medical and scientific information about the results of clinical trials via a website
Owner
- Takeda Pharmaceuticals International AG, Glattpark-Opfikon, CH
- Takeda Pharmaceuticals International AG, Glattpark-Opfikon, CH
Prosecution history
- 21 Feb 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 20 Feb 2026 — SOU EXTENSION 2 GRANTED
- 20 Feb 2026 — SOU EXTENSION 2 FILED
- 20 Feb 2026 — SOU TEAS EXTENSION RECEIVED
- 01 Oct 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 30 Sept 2025 — SOU EXTENSION 1 GRANTED
- 30 Sept 2025 — SOU EXTENSION 1 FILED
- 30 Sept 2025 — SOU TEAS EXTENSION RECEIVED
- 22 Apr 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 25 Feb 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 25 Feb 2025 — PUBLISHED FOR OPPOSITION
- 19 Feb 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 04 Feb 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 04 Feb 2025 — EXAMINER'S AMENDMENT ENTERED
- 04 Feb 2025 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED